Nuveen Churchill Direct Lending Corp. current report, 14 March 2024

Nuveen Churchill Direct Lending Corp. Form 8-K Summary

Reporting date: March 14, 2024; filed March 20, 2024. The filing reports material financing transactions and does not include quarterly financial statements or operating results.

Business Context and Reporting Period

Nuveen Churchill Direct Lending Corp. is a Maryland business development company whose common stock trades on the NYSE under the symbol NCDL. The company completed a collateralized loan obligation financing and amended an existing secured financing facility during the period.

Key Financial and Financing Metrics

  • 2024 Debt Securitization: $296.97 million of term debt issued through Churchill NCDLC CLO-III, LLC, a wholly owned consolidated subsidiary.
  • Class X Notes: $2.0 million, rated AAA, bearing interest at three-month Term SOFR plus 1.40%.
  • Class A Notes: $175.5 million, rated AAA, bearing interest at three-month Term SOFR plus 2.00%.
  • Class B Notes: $37.5 million, rated AA, bearing interest at three-month Term SOFR plus 2.65%.
  • Subordinated Notes: $81.97 million, non-interest-bearing and retained directly by the company.
  • Maturity: The 2024 Notes are due April 20, 2036.
  • Collateral: The notes are backed by a diversified portfolio of senior secured and second-lien loans.
  • Reinvestment: Through April 20, 2028, principal collections may generally be reinvested in new collateral, subject to the indenture and applicable eligibility requirements.
  • Wells Fargo Financing Facility: The maximum facility amount was reduced from $275 million to $150 million, with the potential to increase to $250 million during the reinvestment period with required lender and administrative-agent consent.
  • Undrawn fees: Fees are 0.25% annually during the first three months after the amendment, 0.50% annually for the following six months and thereafter on undrawn amounts up to 40% of the maximum facility, and 1.50% annually on amounts above that threshold.
  • Financial performance: Revenue, net investment income, net income, cash flow, margins, leverage, and liquidity balances are not provided in this filing.

Material Changes Versus the Prior Comparable Period

  • The company added $296.97 million of securitized term debt through the CLO-III transaction.
  • The company retained all subordinated notes, preserving its residual economic interest in the securitization but also exposing it to the first-loss position.
  • The maximum commitment under the Wells Fargo Financing Facility was reduced by $125 million, from $275 million to $150 million, although it may be increased to $250 million subject to consent.
  • The company will act as collateral manager for CLO-III and waive any management fee payable for those services.

Guidance, Outlook, Risks, and Unusual Items

  • The securitization is intended to provide secured financing and allow the company to maintain the initial leverage of the transaction during the reinvestment period.
  • The financing arrangements are secured by loan portfolios and are subject to collateral eligibility criteria, advance rates, covenants, rating-agency requirements, and customary events of default.
  • Interest costs on the Class X, Class A, and Class B notes are floating-rate obligations based on three-month Term SOFR, creating exposure to changes in short-term interest rates.
  • The retained subordinated notes do not bear stated interest and are subordinate to the rated notes, creating residual credit and valuation risk.
  • Principal collections may be reinvested through April 20, 2028, while the Wells Fargo facility’s reinvestment period is scheduled to end March 31, 2025.
  • The 2024 Notes were not registered under the Securities Act or applicable state securities laws and may be offered only pursuant to registration or an applicable exemption.
  • No earnings guidance or broader management outlook is included.

Investor Verification Checklist

  1. Verify the final collateral composition, eligibility tests, advance rates, coverage tests, and other covenant requirements in the CLO-III indenture.
  2. Confirm the outstanding balance, utilization, borrowing base, and availability under the amended Wells Fargo Financing Facility.
  3. Assess the company’s total leverage and liquidity after issuance of the 2024 Notes.
  4. Review the sensitivity of financing costs and net investment income to changes in Term SOFR.
  5. Evaluate the credit quality, valuation, concentration, and non-accrual status of the underlying loan portfolios.
  6. Confirm the economic value and risk profile of the retained subordinated notes.
  7. Review the complete indenture, collateral management agreement, and Third Amendment attached as Exhibits 10.1, 10.2, and 10.3.